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Abstract
Introduction: Severe malaria is a life-threatening medical emergency and requires prompt and effective treatment to
prevent death. There is paucity of published information on current practices of severe malaria case management in sub-
Saharan Africa; we evaluated the management practices for severe malaria in Ugandan health facilities
Methods and Findings: We did a cross sectional survey, using multi-stage sampling methods, of health facilities in 11
districts in the eastern and mid-western parts of Uganda. The study instruments were adapted from the WHO hospital care
assessment tools. Between June and August 2009, 105 health facilities were surveyed and 181 health workers and 868
patients/caretakers interviewed. None of the inpatient facilities had all seven components of a basic care package for the
management of severe malaria consistently available during the 3 months prior to the survey. Referral practices were
appropriate for,10% (18/196) of the patients. Prompt care at any health facility was reported by 29% (247/868) of patients.
Severe malaria was correctly diagnosed in 27% of patients (233).Though the quinine dose and regimen was correct in the
majority (611/868, 70.4%) of patients, it was administered in the correct volumes of 5% dextrose in only 18% (147/815). Most
patients (80.1%) had several doses of quinine administered in one single 500 ml bottle of 5% dextrose. Medications were
purchased by 385 (44%) patients and medical supplies by 478 patients (70.6%).
Conclusions: Management of severe malaria in Ugandan health facilities was sub-optimal. These findings highlight the
challenges of correctly managing severe malaria in resource limited settings. Priority areas for improvement include triage
and emergency care, referral practises, quality of diagnosis and treatment, availability of medicines and supplies, training
and support supervision.
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Introduction
Severe malaria is a life threatening medical emergency
that requires prompt and effective treatment to prevent
death.[1,2] However, effective management of severe malaria
is relatively expensive and relies heavily on well equipped hos-
pitals, with adequately trained health workers, both often
lacking in sub-Saharan Africa.[3,4] Severe malaria has been
described as a neglected disease that poses a significant eco-
nomic burden on most African countries which typically have
weak health systems and are unable to finance basic services
and infrastructure. [5]
In Uganda, efforts to improve the management of severe
malaria at formal health facilities started in 1998, [6] mainly
through training workshops using adapted WHO training
materials. Despite these efforts, severe malaria management
remains challenging, as it depends on the availability of
treatments, blood transfusion services, functional referral systems,
good infrastructure and adequate organization of hospital services.
There is limited information on management practices for severe
malaria in resource constrained settings in Africa, with few studies
reporting on this as part of integrated pediatric care evalua-
tions.[7,8] We evaluated these practices at different levels of health
care in Uganda.
Methods
Ethics statement
The study was approved by the Uganda National Council for
Science and Technology and verbal consent was obtained from all
participants. Verbal consent was considered more appropriate
than written consent for this survey as this was considered a
routine audit/evaluation of health services. Verbal consent was
documented as a tick on each case record form.
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Study design and setting
Between June and August 2009, a cross sectional assessment of
severe malaria management practices was conducted in selected
health facilities in 11 districts in Uganda. For patients with severe
malaria, hospitals and health centre IVs run by specialists, medical
officers and clinical officers provide inpatient services while health
centre IIs and IIIs run by nurses typically provide outpatient and
referral services.
Sampling methodology
Multi-stage sampling methods were used to select study sites.
The eastern and mid-western regions of Uganda were selected to
represent areas of high and low - medium malaria transmission
settings, respectively. Out of 15 districts in these regions, 11 were
randomly selected; 6 in eastern Uganda (Kumi, Soroti, Katakwi,
Bukedea, Amuria and Kaberamaido) and 5 in mid-western
Uganda (Bulisa, Hoima, Kibaale, Kiboga and Masindi). Within
the districts, in order to obtain a representative sample of health
facilities for each region, all hospitals and health centre IVs (in-
patient facilities) were selected while among the 250 health centres
II and III (lower level facilities) 30% were randomly selected. In all
the selected health facilities, the director and the health workers
involved in any aspect of care of malaria patients and available
during the survey days were interviewed. In addition, after having
obtained their or caregivers’ verbal consent, randomly selected
patients having malaria according to the admission register and
hospitalized during the survey days were interviewed.
Data collection
The survey was conducted by 5 teams of 4 to 8 health workers
working in parallel. The teams were trained for 1 week prior to the
survey to ensure that interview questions were appropriately asked
and responses consistently recorded. Training and concordance
testing was done until the agreement of practice results of
interviewers and trainers was .90%. District officials and health
unit directors were informed about the survey only on the morning
of the survey. A triangulation approach was used to collect data
with the following methods: health facility assessments and health
worker interviews at inpatient and lower level facilities as well as
in-patient/caregiver interviews and reviews of patient’s charts at
inpatient facilities. Most survey instruments were adapted from the
WHO hospital care assessment tools. Survey instruments can be
found at www.plosone.org (Appendices S1, S2, S3, S4, S5, S6).
Study coordinators reviewed all survey tools daily for completeness
and accuracy. Health facility assessments collected information on
staffing, triage systems, emergency care, presence of malaria
treatment guidelines, laboratory practices and availability of
medicines and supplies. Health worker assessments collected
information on knowledge of severe malaria and its management,
prescribing practices, training and support supervision. Knowl-
edge on severe malaria management was further assessed using a
clinical case scenario of a patient presenting with fever,
convulsions and loss of consciousness. In-patient/caregiver
interviews and chart reviews collected information on presenting
complaints, time taken to receive care, diagnosis, patients’ weight,
laboratory investigations and treatment prescribed. On average,
17 patients were recruited in each health centre IV and 66 patients
in each hospital. Patients/caregivers were asked to report their
satisfaction with services provided on an ordinal scale (good,
improvement needed or poor) and to suggest improvements. Any
information not obtained through these two approaches was
considered not documented. For missing weights we used a weight
equivalent to the 50% percentile for age according to the 2000
CDC growth charts. [9]
Definitions
Severe malaria case management was assessed according to the
following definitions: correct diagnosis: documented fever or
history of fever with a positive malaria test and at least one
sign/symptom of severe disease according to WHO criteria[10];
prompt management: patient with severe malaria receiving care
within 30 minutes of presentation at the health facility; correct
initial parenteral antimalarial medicine prescribed: administration
of parenteral quinine, artemether or artesunate; correct antima-
larial drug dose and dosing regimen: IV quinine10 mg/kg every
8 hrs (margin of error +/220 mg on total daily dose) or IM
artemether 3.2 mg/kg on day 1, followed by 1.6 mg/kg daily or
IV artesunate 2.4 mg/kg on admission at 12 hrs and then every
24 hrs (margin of error +/25 mg on total daily dose); all given
until the patient was able to tolerate oral therapy. [10,11] Correct
mode of administration: IV quinine in 10–20 ml/kg of 5%
dextrose, intramuscular administration of artemether or IV
artesunate mixed with 5 mL of 5% dextrose and injected as a
bolus; appropriate oral continuation therapy after initial paren-
teral treatment: either oral quinine at 10 mg/kg every 8 hrs until
completion of a 7-day course or a full treatment course of an oral
artemisinin based combination therapy according to appropriate
weight-based dosing guidelines; [10] adequate referral practice:
referral of a patient with severe malaria after administration of
injectable quinine or rectal artesunate, provision of a referral note
and transport[10,11]. Patients were considered appropriately
treated if they received the correct antimalarial medicine, at the
right dose and dosing regimen and with the correct mode of
administration.
Sample size estimation, data management and analysis
For the inpatient interviews, a sample size of 869 inpatients was
estimated assuming 50% of malaria inpatients are appropriately
treated, at 95% level of confidence, with a tolerable error of 0.05, a
design effect of 2 and allowing for 10% non-responsiveness.
Data were double entered in EPI-info software program version
6 and analysed using STATA version 10.0 (StataCorp LP, College
Station, TX, USA). Results from all districts were combined and
descriptive analysis was done at health facility, health worker and
patient levels. Data are presented as proportions and frequencies
adjusted for clustering by health facility. Fisher’s exact tests were
used to analyze differences in proportions. Two tailed p values and
a 5% significance level were used.
Results
In the 11 districts, 105 health facilities were included (83 lower
level facilities and 22 inpatient facilities) and 181 health workers
interviewed (151 at lower level and 50 inpatient facilities
respectively). In addition, 868 inpatient interviews and chart
reviews were conducted. No health worker or caregiver declined to
participate.
Health facility characteristics
The majority of health facilities (83%, 87/105) were govern-
ment-run institutions. Despite health workers’ reports of a defined
triage system in most health facilities, triage was practised in less
than half (44%, 46/105) of them (Table 1). Only 11.4% (12/105)
of health units had separate outpatient (OPD) queues for adults
and children. Functional microscopes for malaria diagnosis were
available in most inpatient units (77.3%, 17/22) and in about half
(51.4%, 18/35) of the health centre IIIs (Table 1). Malaria rapid
diagnostic tests were available in 14.4% (12/83) of health centre
Severe Malaria Case Management
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IIs and IIIs. Haemoglobin measurement was available at 39%
(41/105) of the facilities.
During the 3 months prior to the survey, 54.3% (57/105) of
health facilities had consistent availability of parenteral quinine,
while fewer facilities had quinine tablets (16.2%, 17/105) and
artemether-lumefantrine tablets (33.3%, 35/105). None of the
inpatient facilities had consistent availability of all seven
components of a basic care package for severe malaria
management (parenteral quinine, intravenous fluids, 50% dex-
trose, blood for transfusion, transfusion sets, IV giving sets,
Table 1. Health facility characteristics.
Characteristics N=105
No. %
Health facility level
Health centre II 48 (45.7)
Health centre III 35 (33.3)
Health centre IV 12 (11.5)
District hospital 8 (7.6)
Regional Referral hospital 2 (1.9)
Type of Health facility
Government 87 (82.9)
Faith based 14 (13.3)
Private for profit 4 (3.8)
Treatment aide memoirs in outpatient units available 83 (79.0)
Health facilities with defined triage system 82 (78.1)
Triage practised 46 (43.8)
Presence of separate lines for adults and children in OPD 12 (11.4)
Functional weighing scale available 79 (75.2)
Thermometers available 83 (79.0)
Antimalarial medicines available on the day of survey
Quinine injection 79 (75.2)
IV artesunate 2 (1.9)
Rectal artemisinin 5 (4.8)
Artemether Injection 10 (9.5)
Quinine tablets 41 (39.0)
Artemether-lumefantrine tablets 52 (49.5)
Sulphadoxine-pyrimethamine tablets 64 (60.9)
{Antimalarial medicines available in the 3 months prior to survey
Quinine injection 57 (54.3)
Quinine tablets 17 (16.2)
Artemether-lumefantrine tablets 35 (33.3)
{,{Supplies for severe malaria management available in the 3 months prior to survey at the inpatient units (N=22)
5% dextrose 8 (36.4)
50% dextrose 7 (31.8)
Blood for transfusion 1 (4.5)
Blood transfusion sets 8 (36.4)
IV giving sets 10 (45.5)
Availability of seven basic medicines and supplies for severe malaria management in the 3 months prior to survey at inpatient units* 0 (0)
{Malaria testing facilities available
Functional microscope at inpatient units (N = 22) 17 (77.3)
Functional microscope at health centre IIIs (N = 35) 18 (51.4)
RDTs at health centre IIs and IIIs (N = 83) 12 (14.4)
*Basic package includes: Quinine injection, Intravenous fluids, 50% dextrose, blood for transfusion, IV giving sets, blood transfusion set, Syringes.
{Stock-outs defined as the absence of medicines or supplies for .1 week in the 3 months prior to the survey.
{Denominators indicated in brackets.
doi:10.1371/journal.pone.0017053.t001
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syringes). The most common stock outs were blood for transfusion
(available in 4.5% of units), 50% dextrose (in 32%), 5% dextrose
and transfusion sets (in 36.4%) (Table 1).
Health worker characteristics
At the inpatient units, nurses/midwives represented the
majority of the staff (40%). Considering all health facilities visited,
only 2 doctors were on duty on survey days. The percentage of
health workers who could mention.2 severe forms of malaria was
24% at the inpatient units and only 2.3% at the lower levels of
care. In response to the clinical case scenario, 52% (26) of health
workers at the inpatient level and 49.6% (65) at the lower levels of
care were able to write an accurate prescription for a 4 year old
patient (Table 2). Regarding on-site training, 22.2% (28/131) of
health workers at the lower levels of care and 22.0% (11/50) at the
inpatient units reported having received in-service training on
severe malaria management within the year prior to the survey.
Fewer health workers at the inpatient units (24.0%, 12/50) than
those at the lower levels of care (41.9%, 55/131) (p = 0.025)
reported having received at least one support supervision visit in
the previous 6 months. (Table 2)
Patient assessment and emergency care
The majority of patients (76.3%, 663/868) were aged ,5 years;
the median age being 2 years. Fever or history of fever was the
commonest reason for attendance (96.6%). Mean duration of
hospitalisation at the time of interview was 2.5 days (SD 1.5), with
546 patients (62.9%) hospitalised for #2 days, 221 (25.5%) for #1
day and 142 (16.4%) for $4days. Malaria or severe malaria was
the diagnosis documented in 93.8% of patients (814/868). Among
these, 103 (11.9%) were recorded as malaria with severe anaemia
(45% confirmed by microscopy) and 21 (2.4%) as cerebral malaria
(57% confirmed by microscopy).
The median waiting time before receiving care at the facility was
3.0 hours (range 0–24 hours) with 28.5% (247/868) of patients
reporting having received care within the first 30 minutes and 52.3%
(454/868) within 1 hour of attendance. At least 33 patients (3.8%)
waited $8 hours before receiving any care. Though most patients
were asked about their age (96.3%), history of fever (89%), prior use
of antimalarial therapy (58%) and history of repeated vomiting (55%),
patients/caretaker reports and chart reviews revealed that presence of
common danger signs were not often elicited (history of convulsions in
303 (35%) and drowsiness in 248 (29%) patients). Body temperature
and level of consciousness were assessed in 20.5% (178/868) and
23.6% (205/868) of patients, respectively. The proportion of patients
with at least one sign or symptom of severe malaria documented was
27.9% (242/868). Malaria infection was confirmed by microscopy in
64.7% (432/668) of patients in health facilities where functional
microscopy was available.
Case management practises
One hundred ninety six patients (23%) had been referred from a
lower level of health care. The main reasons for referral were: poor
response to treatment (38%) or unavailability of either blood for
Table 2. Health worker Characteristics.
Characteristics
Lower level units:
Health centre II and
III (N=131) No. (%)
Inpatient units:
Hospitals and Health
centre IV (N=50) No. (%) P value
Pre-service training
Medical officer 0 2 (4.0%) 0.02
Clinical officer 9 (6.9%) 14 (28.0%) 0.00
Nurse/midwife 36 (27.5%) 20 (40.0%) 0.12
Nursing aide/assistant 86 (65.7%) 14 (28.0%) 0.00
In service at current post for .12 months 97 (74%) 39 (78.0%) 0.58
Diagnosis of malaria based on clinical features and diagnostic tests (confirmatory) 11 (8.9%) 26 (52.0%) 0.00
Health worker ever undergone IMCI training 62 (49.6%) 28 (56.0%) 0.47
Received in-service training on severe malaria case management in last 12 months 28 (22.2%) 11 (22.0%) -
Health worker has malaria treatment guidelines accessible 108 (82.4%) 43 (86.0%) 0.52
Knowledge on severe malaria
Common forms of severe malaria listed
Severe anaemia 6 (4.6%) 38 (76%) 0.00
Repeated convulsions 8 (6.1%) 35 (70%) 0.00
Cerebral malaria 93 (71.0%) 27 (54%) 0.03
Hypoglycaemia 14 (10.7%) 17 (34%) 0.00
Shock 2 (1.5%) 15 (30%) 0.00
Spontaneous bleeding 65 (49.6%) 5 (10%) 0.00
Pulmonary oedema 18 (13.7%) 1 (2) 0.02
Response to hypothetical clinical case
Correct antimalarial medicine choice 113 (89.7%) 48 (98%) 0.03
Correct quinine prescription for child 65 (49.6%) 26 (52%) 0.81
Correct quinine prescription for adult 93 (71.1%) 40 (80%) 0.22
doi:10.1371/journal.pone.0017053.t002
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transfusion (33%), intravenous fluids (18%) or beds (9%). Pre-
referral medications were given to 145 (79%) patients, quinine in
39.3% (57/145), often administered alone (65%, 37/57), or with an
antibiotic (13%), an antipyretic (15%) or diazepam (5%). No patient
received pre-referral rectal artesunate, referral notes were provided
for 58.7% (115/196) and transport for only 6.1% (12/196). Overall,
9.2% (18/196) patients referred had adequate referral practises;
1.3% (1/76) in the low-medium transmission setting and 14.2%
(17/120) in the high transmission setting (p= 0.002).
Two hundred thirty three (27%) patients had a correct diagnosis
of severe malaria. The proportion of patients with a correct diagnosis
was higher in the high transmission setting, 29.7% compared to
17.9% in the low-medium transmission setting (p= 0.001). Most
patients were evaluated at least once a day during their
hospitalization, though 102 (13%) were never assessed (Table 3).
The majority of patients (95%, 823/868) received the correct initial
parenteral antimalarial medicine, often at the recommended dose
and dosing regimen (70.4%, 611/868). However, the dose was
inappropriate in all 8 patients treated with artemether. For patients
treated with quinine, 75% (611/815) were correctly dosed, 12.7%
(104/815) were under dosed and 12.3% (12.3%) over dosed. Among
patients treated with quinine, 18% (147/815) received the correct
dosing regimen and mode of administration. Significantly, in most
cases (75%) multiple doses of quinine were administered in a single
500 ml bottle of 5% dextrose to run over 24 to 48 hours. The
proportion of in-patients with a negative blood smear but receiving
antimalarial treatment was 94.9% (129/136). Overall, only 16.9% of
the patients were appropriately treated for severe malaria. (Table 3)
Medications needed for treatment were purchased by 385 (44%) and
medical supplies by 478 patients (70.6%) at a mean cost of $2.8 (SD
2.9) and $3.4 (SD 3.7), respectively.
Almost half of the patients (43.3%) considered that they had
waited too long before seeing any health worker at presentation
and 45% thought that services offered needed further improve-
ments. Quality of care at the health facilities was reported as good
by 46.8% of patients/caretakers, 45% thought that services offered
needed to be improved while 8.2% thought services were poor.
Suggestions for improvement included having sufficient medicines
at health units (21.3%), improving the availability of supplies and
sundries (11.6%), increasing the number of staff (8.3%), providing
more beds and beddings (7.6%) and health workers having better
attitudes towards patients and attendants (7.1%).
Table 3. Case management practises for patients hospitalised with a diagnosis of malaria.
N= 868
No. %
95% CI
(Cluster
adjusted)
Patients with a negative blood smear receiving antimalarial treatment (N = 136) 129 94.9% 87.8–100
Reported frequency of evaluation by health workers during hospitalization
Once every day 410 50.1
Twice or thrice daily 265 32.4
Never seen 102 12.5
Patients purchasing medications 385 44 34.8–53.9
Purchased medications 214 44.5
Quinine 76 15.8
Antibiotics 38 7.9
Haematinics
Patients purchasing medical supplies 478 70.6 61.7–79.5
Purchased medical supplies 223 33.4
Intravenous cannula 162 24.3
Intravenous fluids 109 16.3
Syringes 101 15.0
Giving sets 27 4.0
Gloves
Correct antimalarial treatment 823 94.8 91.7–98.7
Initial parenteral antimalarial medicine prescribed
Quinine 815 93.9
Artemether 8 0.9 51.9–87.3
Initial parenteral antimalarial medicine dose and dosing regimen 611 70.4 12.0–21.9
Initial parenteral antimalarial medicine, dosing regimen and mode of administration (appropriately treated) 147 16.9
Oral continuation therapy (n =486) 429 88.3
Oral quinine 274 63.9 28.8–85.3
Artemether-lumefantrine 149 34.7 15.1–47.0
Dihydroartemisinin-piperaquine 6 1.4 0–3.4
doi:10.1371/journal.pone.0017053.t003
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Discussion
In our survey, management of severe malaria in Ugandan
health facilities was sub-optimal, with most facilities not fully
complying with the national and international treatment guide-
lines. We found significant problems with case management at
both the health system/health centre and provider levels. Indeed,
this survey identified several problems at different levels of the
health care system, from the referral practices at the lower level
health centres to the availability of supplies and actual manage-
ment of malaria cases in referral facilities. Despite the existence of
some differences between the two regions, the problems identified
in the management of severe malaria cases were similar, indicating
that both regions need similar attention and efforts to improve this
unacceptable situation. Though the quality of documentation may
have impacted on our assessment, we believe these findings
accurately represent the management practices in these settings.
Practices related to severe malaria case management were
deficient, from patient evaluation, for which the presence of
danger signs were not systematically checked, to diagnosis,
correctly done in ,30% of patients, and treatment, which was
usually correct in terms of dose and dosing regimen but for which
drug administration was often not done as recommended.
Deficiencies in correctly diagnosing severe malaria suggest that a
significant proportion of these patients may have had uncompli-
cated malaria and did not require parenteral therapy or
hospitalisation. This calls for measures to improve patient
evaluation and promotion of the rational use of antimalarial
medicines. Furthermore, none of the inpatient health facilities had
all components of a basic care package for severe malaria
management available, with blood for transfusion, 5% dextrose,
and transfusion sets least available.
Though the survey was not designed to evaluate the impact of
management practices on clinical outcome, it would be expected
that such shortcomings would influence patient survival. The large
majority of patients included in this survey had already gone
through the first 24–48 hours of hospitalization, a known critical
period,[12] and may not fully represent treatment practices in
those with a fatal outcome. Therefore, the quality of case
management might be worse than documented here.
When analysing these observations in more detail, patient triage,
evaluation and diagnosis were extremely inadequate. More than
half of health facilities did not practise triage and few had separate
OPD queues for adults and children, an important element as the
large majority of the patients were children ,5 years of age. Such
inefficient systems may explain the long waiting times prior to
receiving care at the health facilities. Good quality emergency care
and triage is a critical first step in improving hospital care;
unfortunately, triage is often deficient in resource limited settings.
[7,13]This worrying finding can be addressed by training health
workers on emergency triage, assessment, and treatment [14] and
by providing practical support through supervision and clinical
audits. This strategy would not only improve the management of
severe malaria cases but also that of other severely ill patients.
Though health worker training has been shown to be critical for
improving case management, [15–16]the cadre of health workers to
be targeted needs to be critically reconsidered. In our setting, nurses
and nursing aides, though not primarily responsible for clinical
management decision taking, should have the priority as they were
the only cadre of staff consistently available at the units whereas
medical and clinical officers, who theoretically have the primary
responsibility, were consistently absent.
The proportion of in-patients with a negative blood smear but
receiving antimalarial treatment was substantial. This finding has
previously been reported in similar settings, with an increased risk
of death in these patients when treated for malaria, possibly due to
inappropriate treatment of other illnesses [17,18,19]. In our
setting, there was also significant concurrent administration of
antibiotics that could be attributed to diagnostic uncertainty.
Routine treatment with parenteral antibiotics may be warranted,
particularly when microscopy is not available or of insufficient
quality, because of the increased risk of bacterial sepsis and
associated mortality in malaria patients [20]. The recent decision
by the Ugandan Ministry of Health to have all suspected malaria
cases confirmed by microscopy or rapid diagnostic test may
improve diagnosis. The challenge though remains to ensure
consistent availability of these tools at all facility-based service
delivery points.
The adequacy of treatment dose, dosing schedule and oral
continuation therapy in our survey is reassuring; the latter was
probably due to recent in-service training conducted on the
management of uncomplicated malaria at the time of treatment
policy change in Uganda in 2006. However, the method of
quinine administration is a cause of concern. Most patients had
multiple doses of quinine (for 24 to 48 hours) combined in a single
500 ml bottle of 5% dextrose. The rationale for this practise is
unclear; but may be due to the desire to minimize costs.
Nevertheless, this practice is concerning and should be discour-
aged as it increases the risk of both quinine toxicity and fluid
overload, particularly in children. The provision of smaller volume
bottles for infusion, more suitable for paediatric patients, may
overcome this problem. In addition, the use of artesunate
injections may further improve treatment delivery as this regimen
does not require rate-controlled infusion. The SEAQUAMAT[21]
and recently published AQUAMAT study [22] provide sufficient
evidence of the superiority of artesunate over quinine in both
children and adults and this should lead to severe malaria
treatment policy change to intravenous artesunate in several Sub-
Saharan countries, including Uganda. In our study, the alternative
to quinine in a few patients was artemether, which was always
administered at an incorrect dosage, possibly because the heath
providers had little experience with this product.
Importantly, stock-outs of several items included in the basic
care package for severe malaria management were common and
could explain the high proportion of patients obliged to purchase
medications and supplies needed for their management. This is
certainly a major challenge, as improving clinical skills through
training without ensuring availability of medicines and supplies
will have limited impact on the quality of care. These shortages
impact negatively on efforts to deliver effective treatment and
undermine malaria control efforts. [23] Such stock-outs are caused
by different factors and often reflect weaknesses in medicine and
supplies procurement, management and distribution practices.
Indeed, in this study inadequate and delayed funding, delayed
drug deliveries and poor storage were identified as the main causes
of stock-outs (data not presented). This problem must be addressed
by the Ugandan Ministry of Health as a matter of priority to
improve the quality of care and minimize out-of-pocket costs
incurred by patients/caregivers, which were unacceptably high for
a country like Uganda where 52% of the population lives below
the international poverty line of US$1.25 per day[24]. Shortages
may also be curtailed by measures to improve severe malaria
diagnosis and by the use of diagnostic tests to improve targeting of
treatment. It is also critical for resource limited countries like
Uganda to look for more efficient ways of financing health care as
the current system does not seem to mobilize sufficient resources to
provide the desired levels for the entire population [25]. At the
national and international level, much more attention appears to
Severe Malaria Case Management
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be focused on community-based health care interventions. There
is need to shift some of this attention back to facility-based health
care services, especially since community service delivery is linked
to that at health units.
In conclusion, this study highlights the serious challenges faced
in the management of severe malaria in a resource limited setting
like Uganda. There is paucity of published information on current
severe malaria management practices in sub-Saharan Africa, but
the situation in many areas may not be very different from what
we have observed in Uganda. Considering the problems identified,
several priority areas at different points of care needing
improvement would include: patient assessment, referral practices,
quality of diagnosis, triage and emergency care, treatment
practices, availability of medicines and supplies, health worker
training and support supervision. Considering its huge toll on
African children, improved management of severe malaria should
be a priority.
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